ABL1-C-HiBiT
(Plasmid
#234568)
-
PurposeBacterially expressed ABL1-C-HiBiT for Ni-NTA purification
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 234568 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepET21a (+)
-
Backbone manufacturerNovagen
- Backbone size w/o insert (bp) 5409
- Total vector size (bp) 6318
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert nameAbelson Kinase Domain
-
Alt nameABL proto-oncogene 1, non-receptor tyrosine kinase
-
Alt nameABL1-C-HiBiT
-
SpeciesH. sapiens (human)
-
Insert Size (bp)921
-
MutationCodon optimized for bacterial expression
-
GenBank IDNG_012034.1
-
Entrez GeneABL1 (a.k.a. ABL, BCR-ABL, CHDSKM, JTK7, bcr/abl, c-ABL, c-ABL1, p150, v-abl)
- Promoter T7
-
Tags
/ Fusion Proteins
- T7 gene 10 leader peptide (N terminal on insert)
- HiBiT Tag-thrombin site-10xHis (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamH1 (unknown if destroyed)
- 3′ cloning site Xho1 (unknown if destroyed)
- 5′ sequencing primer T7 promoter primer #69348-3
- 3′ sequencing primer T7 terminator primer #69337-3 (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made bysynthesis by Genscript
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
ABL1-C-HiBiT was a gift from James Inglese (Addgene plasmid # 234568 ; http://n2t.net/addgene:234568 ; RRID:Addgene_234568) -
For your References section:
A general assay platform to study protein pharmacology using ligand-dependent structural dynamics. Ciulla DA, Dranchak PK, Aitha M, van Neer RHP, Shah D, Tharakan R, Wilson KM, Wang Y, Braisted JC, Inglese J. Nat Commun. 2025 May 10;16(1):4342. doi: 10.1038/s41467-025-59658-6. 10.1038/s41467-025-59658-6 PubMed 40346061